Dr. Pinter-Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-456-8000Fax+1 714-456-7142- Is this information wrong?
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1984 - 1986
- University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1983 - 1984
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1980 - 1983
- David Geffen School of Medicine at UCLAClass of 1980
Certifications & Licensure
- CA State Medical License 1981 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 2004 Dec 01
- Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Start of enrollment: 2004 Jul 01
- GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Alopecia areata-like presentations with mogamulizumab therapy.Colin M Kincaid, Ajay N Sharma, Bonnie A Lee, Lauren C Pinter-Brown, Janellen Smith, Kenneth Linden, Natasha A Mesinkovska> ;JAAD Case Reports. 2023 Nov 1
- 1 citationsSOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCL.Danielle Brazel, Lauren Pinter-Brown> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
- 1 citationsIdentifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.Pietro Quaglino, Julia Scarisbrick, Gabriele Roccuzzo, Alejandra Abeldano, Maxime Battistella, Chris McCormack, Richard Cowan, Antonio Cozzio, Jade Cury-Martins, Paula...> ;Journal of the European Academy of Dermatology and Venereology. 2023 Apr 1
- Join now to see all
Journal Articles
- Phase 2 Study of Everolimus for Relapsed or Refractory Classical Hodgkin LymphomaPatrick B. Johnston, Radhakrishnan Ramchandren, Lauren C. Pinter-Brown, BioMed Central
Press Mentions
- SOHO 2021: An Update of Lymphoma Treatments in Five PartsSeptember 20th, 2021
- New Publication Offers Insight into POTELIGEO® (Mogamulizumab-Kpkc) Treatment Response in Cutaneous T-cell Lymphoma Patients with Varying Levels of Blood InvolvementJuly 22nd, 2021
- Nephrotic Syndrome Reported with Everolimus, VoriconazoleJuly 8th, 2017
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
- UCI HealthOrange, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: